Advertisement
Canada markets closed
  • S&P/TSX

    22,167.03
    +59.95 (+0.27%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CAD/USD

    0.7376
    -0.0011 (-0.14%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • Bitcoin CAD

    95,347.30
    +404.41 (+0.43%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • RUSSELL 2000

    2,124.55
    +10.20 (+0.48%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ

    16,379.46
    -20.06 (-0.12%)
     
  • VOLATILITY

    13.01
    +0.23 (+1.80%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     
  • CAD/EUR

    0.6844
    +0.0001 (+0.01%)
     

Ackermans & van Haaren: Annual results 2020

Dear,


  • Ackermans & van Haaren realised a net profit of 229.8 million euros over the full year 2020.

  • Despite the continuing impact of the corona pandemic into the second half of the year, the results of the group made a strong recovery (net profit H2 2020: 173.5 million euros).

  • An increase of the dividend to 2.35 euros per share is proposed to the general meeting of shareholders.


“I am extremely proud of the resilience shown by our 22,331 colleagues throughout the AvH group amidst these uncertain and volatile times caused by the COVID crisis. Over 2020, the AvH group realises a very solid net profit of 230 million euros.

Based upon strong portfolio performances, both Delen Private Bank and Bank J.Van Breda & C° realised very strong inflows of new assets under management that have reached a record level of more than 54 billion euros at year-end 2020. On the back of a strong push towards more renewable energy sources and greening the world economy, DEME increased its order backlog to a record level of more than 4.5 billion euros.

We remain committed to invest in strengthening our portfolio, and investing in a more sustainable and digital savvy world, as illustrated by our recent investments in OMP, Verdant Bioscience, Medikabazaar and Indigo Diabetes.”

Jan Suykens, CEO - Chairman of the executive committee

ADVERTISEMENT


You can watch the video message of Jan Suykens, CEO of Ackermans & van Haaren, about the annual results on our website or read our press release via the link below.

Best regards

Ackermans & van Haaren


Attachment